In contrast to normal tissues, the expression level of ETS1 in STAD samples with TP53 mutation was significantly upregulated, while the expression level of ETS1 in STAD samples with TP53 nonmutation was further significantly upregulated (P < 0.001, Fig. 4C). This evidence concerns the gene TP53 and gastric adenocarcinoma.